Ascendis Pharma A/S Annual Reports (10-K)
Every annual report 10-K going back 5 years. Put here in one place for you.
Page 1 of 5
2025-2021
| Currency in EUR | 2025 |
|---|---|
| Operating Income | -136.27 Million |
| Income Before Tax | -212.65 Million |
| Income Tax Expense | 15.38 Million |
| Net Income | -228.03 Million |
| Eps | -3.76 |
| Epsdiluted | -3.76 |
| Weighted Average Shs Out | 60.61 Million |
| Weighted Average Shs Out Dil | 60.61 Million |
| Depreciation And Amortization | 17.70 Million |
| Interest Expense | 80.65 Million |
| Ebit | -132 Million |
| Interest Income | 15.30 Million |
| Net Interest Income | -44.88 Million |
| Period | FY |
| Ebitda | -118.58 Million |
| Net Cash Provided By Operating Activities | N/A |
| Source | yahoo |